Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan

Background It is estimated that approximately 10 million individuals in Pakistan are infected with hepatitis C virus (HCV). Historically, it was very difficult not just to cure but even treat HCV as available options did not have desirable outcomes. However, the approval of directly acting antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Nazish, Reema, Sehrish, Ali Khan, M, Abbasi, Amanullah, Butt, Sehrish, Khoso, Mohammad M, Akbar, Ali, Haleem, Farhan, Mahesar, Ghulam B, Fahad, Anoshia, Qureshi, Talha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561614/
https://www.ncbi.nlm.nih.gov/pubmed/31205844
http://dx.doi.org/10.7759/cureus.4458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561614/
https://www.ncbi.nlm.nih.gov/pubmed/31205844
http://dx.doi.org/10.7759/cureus.4458

Ejemplares similares